368 related articles for article (PubMed ID: 7513254)
1. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
[TBL] [Abstract][Full Text] [Related]
2. Effect of tecogalan sodium on angiogenesis in vitro by choroidal endothelial cells.
Sakamoto T; Ishibashi T; Kimura H; Yoshikawa H; Spee C; Harris MS; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1076-83. PubMed ID: 7537258
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity.
Odekon LE; Sato Y; Rifkin DB
J Cell Physiol; 1992 Feb; 150(2):258-63. PubMed ID: 1734031
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
[TBL] [Abstract][Full Text] [Related]
5. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.
Jimi S; Ito K; Kohno K; Ono M; Kuwano M; Itagaki Y; Ishikawa H
Biochem Biophys Res Commun; 1995 Jun; 211(2):476-83. PubMed ID: 7540839
[TBL] [Abstract][Full Text] [Related]
6. A diaminoantraquinone inhibitor of angiogenesis.
Takano S; Gately S; Jiang JB; Brem S
J Pharmacol Exp Ther; 1994 Nov; 271(2):1027-33. PubMed ID: 7525934
[TBL] [Abstract][Full Text] [Related]
7. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane.
Danesi R; Del Bianchi S; Soldani P; Campagni A; La Rocca RV; Myers CE; Paparelli A; Del Tacca M
Br J Cancer; 1993 Nov; 68(5):932-8. PubMed ID: 7692920
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro.
Gajdusek CM; Luo Z; Mayberg MR
J Cell Physiol; 1993 Oct; 157(1):133-44. PubMed ID: 7691833
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
Gualandris A; Presta M
J Cell Physiol; 1995 Mar; 162(3):400-9. PubMed ID: 7860647
[TBL] [Abstract][Full Text] [Related]
11. Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells.
Peverali FA; Mandriota SJ; Ciana P; Marelli R; Quax P; Rifkin DB; Della Valle G; Mignatti P
J Cell Physiol; 1994 Oct; 161(1):1-14. PubMed ID: 7523424
[TBL] [Abstract][Full Text] [Related]
12. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells.
Pepper MS; Wasi S; Ferrara N; Orci L; Montesano R
Exp Cell Res; 1994 Feb; 210(2):298-305. PubMed ID: 7507853
[TBL] [Abstract][Full Text] [Related]
13. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
Hasselaar P; Sage EH
J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864
[TBL] [Abstract][Full Text] [Related]
14. Regulation of urokinase-type plasminogen activator production by rat mammary myoepithelial cells.
Warburton MJ; Dundas SR; Gusterson BA; O'Hare MJ
Exp Cell Res; 1996 Oct; 228(1):76-83. PubMed ID: 8892973
[TBL] [Abstract][Full Text] [Related]
15. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling.
Lee TH; Lee HC; Son YS; Kang MA; Park MJ; Nam MJ; Lee SH; Hong SI
Endothelium; 2006; 13(3):191-203. PubMed ID: 16840175
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
Goto F; Goto K; Weindel K; Folkman J
Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
[TBL] [Abstract][Full Text] [Related]
19. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells.
Iwasaka C; Tanaka K; Abe M; Sato Y
J Cell Physiol; 1996 Dec; 169(3):522-31. PubMed ID: 8952701
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]